Gw Pharmaceuticals reported $583K in Ordinary Share Capital for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Adamas Pharmaceuticals ADMS:US 50K 0
Aerie Pharmaceuticals AERI:US $ 0.05M 0M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alexion Pharmaceuticals ALXN:US $ 0M 0M
ALKERMES ALKS:US $ 1.65M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.2M 0.01M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bluebird Bio BLUE:US $ 0.7M 0.02M
Clovis Oncology CLVS:US $ 0.13M 0.01M
Flexion Therapeutics FLXN:US $ 50K 0
Gw Pharmaceuticals GWPH:US $ 0.58M 0.01M
Heron Therapeutics HRTX:US $ 1.02M 0M
Moderna Inc MRNA:US 40.5K 40.5K
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Prothena PRTA:US $ 0.46M 0.02M
Ptc Therapeutics PTCT:US $ 0.07M 0M
Puma Biotechnology PBYI:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vertex Pharmaceuticals VRTX:US $ 2.56M 0.03M
YTE INCY:US $ 0.22M 0M